---
title: "Signatures of Immune Oncology"
summary: "Immune oncology signatures categorized by their functions and associated cell types."
description: "Immune oncology signatures categorized by their functions and associated cell types."
tags: ["TME", "Immune", 'IFN']
categories: ["Immune"]
ShowToc: false
TocOpen: false
date: "2024-05-31"
---

| Signature                        | Genes                                                                                       |
|----------------------------------|--------------------------------------------------------------------------------------------|
| Antigen Presenting Machinery     | B2M, HLA-A, TAP1, TAP2, CD81, LAG3                                                         |
| Apoptosis                        | BAX, BCL2L1                                                                                 |
| Cytotoxicity                     | GNLY, GZMA, GZMB, GZMH, PRF1                                                                |
| Glycolytic Activity              | AKT1, ENO1, GLUD1, HIF1A, LDHA, SLC2A1, TPI1                                                |
| Hypoxia                          | SLC2A1, PLIN2, ADM, ADORA2B, AK4, ALDOC, ANG, ATF3, BNIP3, BNIP3L, CA9, CA12, CAV1, CCNG2, KLF6, DUSP1, EFNA1, ENO2, F3, FOS |
| IFN Downstream Signaling         | IFI27, IFI6, IFIH1, IFIT1, IFIT3, IFITM1, ISG15, MX1, OAS1, OAS2                             |
| IFN_Gamma_Signaling              | CXCL10, CXCL9, STAT1                                                                        |
| Inflammatory Chemokines          | CCL2, CCL4, CCL8                                                                            |
| Lymphoid                         | CD2, CD27, CD38, CD3D, CD3E, CD3G, CD40LG, CD48, CD79A, CD8A, CD8B, CTLA4, CX3CL1, CXCL10, CXCL13, CXCL9, CXCR3, EOMES, GNLY, GZMA, GZMB, GZMH, GZMK, ICOS, IDO1, IFITM1, IFNG, IGF2R, IL2RG, IRF4, JAK1, JAK2, KLRB1, KLRK1, LAG3, MS4A1, PDCD1, PRF1, STAT1, TBX21, TIGIT |
| MHC2                             | CD74, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRA, HLA-DRB1                                         |
| Myeloid Inflammation             | AREG, CCL20, CSF3, CXCL1, IER3, IL6, PTGS2                                                   |
| Proliferation                    | CENPF, MKI67, UBE2C                                                                          |
| Tumor Inflammation Signature     | CCL5, CD27, CD274, CD276, CD8A, CMKLR1, CXCL9, CXCR6, HLA-DQA1, HLA-DRB1, IDO1, LAG3, NKG7, PDCD1LG2, STAT1, TIGIT |
| Tertiary Lymphoid Structure (TLS) | CD19, CD20, CETP, CCR7, SELL, LAMP3, CCL19, CXCL9, CXCL10, CXCL11, CXCL13, CD208, CD3         |

<cite>These signatures were collected from `nanostring.com` [^1]</cite>

[^1]: [Spatial Transcriptomic signatures of the fundamentals of immune oncology](https://nanostring.com/wp-content/uploads/2023/11/SITC-2023_156_Poster_CosMx_Spatial-transcriptomic-signatures-UPC_Sangsoon_Patrick-D_Approved.pdf) 
